Boase Cohen & Collins (Hong Kong): An injection of hope amid travel impasse

This pandemic-weary world could do with a shot in the arm right now and pharmaceutical giant Pfizer believes it can provide one. The American firm and German partner BioNTech this week announced their Covid-19 vaccine is more than 90% effective in trials involving some 43,000 volunteers, an impressive statistic considering the World Health Organization sets the bar for a successful jab at 50%. If American and European drug regulators allow them to proceed, Pfizer and BioNTech are expected to manufacture over 1.3 billion doses for use worldwide by the end of 2021. MORE.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Related Posts

Categories

Categories